These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 18692250)
21. The association between suicidality and treatment with selective serotonin reuptake inhibitors in older people with major depression: a systematic review. KoKoAung E; Cavenett S; McArthur A; Aromataris E JBI Database System Rev Implement Rep; 2015 Apr; 13(3):174-205. PubMed ID: 26447056 [TBL] [Abstract][Full Text] [Related]
22. Suicide prevention and serotonergic drugs. Montgomery SA Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():83-5. PubMed ID: 8201249 [TBL] [Abstract][Full Text] [Related]
23. Assessing the role of drugs in suicidal ideation and suicidality. Reith DM; Edmonds L CNS Drugs; 2007; 21(6):463-72. PubMed ID: 17521226 [TBL] [Abstract][Full Text] [Related]
24. A naturalistic study of suicidal adolescents treated with an SSRI: suicidal ideation and behavior during 3-month post-hospitalization period. Ghaziuddin N; Merchant C; Dopp R; King C Asian J Psychiatr; 2014 Oct; 11():13-9. PubMed ID: 25453691 [TBL] [Abstract][Full Text] [Related]
25. Antidepressant class, age, and the risk of deliberate self-harm: a propensity score matched cohort study of SSRI and SNRI users in the USA. Miller M; Pate V; Swanson SA; Azrael D; White A; Stürmer T CNS Drugs; 2014 Jan; 28(1):79-88. PubMed ID: 24146116 [TBL] [Abstract][Full Text] [Related]
26. The role of 5-HT1A receptors in mediating acute negative effects of antidepressants: implications in pediatric depression. Rahn KA; Cao YJ; Hendrix CW; Kaplin AI Transl Psychiatry; 2015 May; 5(5):e563. PubMed ID: 25942044 [TBL] [Abstract][Full Text] [Related]
27. Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a brief report. Meyer RE; Salzman C; Youngstrom EA; Clayton PJ; Goodwin FK; Mann JJ; Alphs LD; Broich K; Goodman WK; Greden JF; Meltzer HY; Normand SL; Posner K; Shaffer D; Oquendo MA; Stanley B; Trivedi MH; Turecki G; Beasley CM; Beautrais AL; Bridge JA; Brown GK; Revicki DA; Ryan ND; Sheehan DV J Clin Psychiatry; 2010 Aug; 71(8):1040-6. PubMed ID: 20673551 [TBL] [Abstract][Full Text] [Related]
28. TORDIA: unique opportunity to explore half-life theory. Smith E Am J Psychiatry; 2009 Aug; 166(8):936; author reply 936-7. PubMed ID: 19651756 [No Abstract] [Full Text] [Related]
29. Efficacy and safety of antidepressant drug treatment in children and adolescents. Henry A; Kisicki MD; Varley C Mol Psychiatry; 2012 Dec; 17(12):1186-93. PubMed ID: 22064376 [TBL] [Abstract][Full Text] [Related]
30. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy. Akiskal HS; Benazzi F; Perugi G; Rihmer Z J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694 [TBL] [Abstract][Full Text] [Related]
31. The ethics of paediatric anti-depressant use: erring on the side of caution. Shearer MC; Bermingham SL J Med Ethics; 2008 Oct; 34(10):710-4. PubMed ID: 18827099 [TBL] [Abstract][Full Text] [Related]
32. Impact of the 2004 Food and Drug Administration pediatric suicidality warning on antidepressant and psychotherapy treatment for new-onset depression. Valluri S; Zito JM; Safer DJ; Zuckerman IH; Mullins CD; Korelitz JJ Med Care; 2010 Nov; 48(11):947-54. PubMed ID: 20856141 [TBL] [Abstract][Full Text] [Related]
33. Pediatric antidepressant use after the black-box warning. Busch SH; Barry CL Health Aff (Millwood); 2009; 28(3):724-33. PubMed ID: 19414881 [TBL] [Abstract][Full Text] [Related]
34. Do antidepressants t(h)reat(en) depressives? Toward a clinically judicious formulation of the antidepressant-suicidality FDA advisory in light of declining national suicide statistics from many countries. Rihmer Z; Akiskal H J Affect Disord; 2006 Aug; 94(1-3):3-13. PubMed ID: 16712945 [TBL] [Abstract][Full Text] [Related]
35. Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort. Tiihonen J; Lönnqvist J; Wahlbeck K; Klaukka T; Tanskanen A; Haukka J Arch Gen Psychiatry; 2006 Dec; 63(12):1358-67. PubMed ID: 17146010 [TBL] [Abstract][Full Text] [Related]
36. Potential effects of antidepressant agents on the growth and development of children and adolescents. Nardi DA; Barrett S J Psychosoc Nurs Ment Health Serv; 2005 Jan; 43(1):22-35. PubMed ID: 15685843 [TBL] [Abstract][Full Text] [Related]
37. Antidepressants and suicidality: the basis of controversies. Marcinko D Psychiatr Danub; 2007 Sep; 19(3):238-40. PubMed ID: 17914327 [TBL] [Abstract][Full Text] [Related]
38. Suicidal behaviour in youths with depression treated with new-generation antidepressants: meta-analysis. Dubicka B; Hadley S; Roberts C Br J Psychiatry; 2006 Nov; 189():393-8. PubMed ID: 17077427 [TBL] [Abstract][Full Text] [Related]
39. Does treatment with antidepressant medication increase suicidal behavior? Goldblatt MJ; Schatzberg AF Int Clin Psychopharmacol; 1991; 6(4):219-26. PubMed ID: 1816279 [TBL] [Abstract][Full Text] [Related]
40. [SSRIs (selective serotonin reuptake inhibitors) and suicidality in adults, adolescents and children]. Tandt H; Audenaert K; van Heeringen C Tijdschr Psychiatr; 2009; 51(6):387-93. PubMed ID: 19517368 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]